Our flagship innovation, CORGEE, is an objective test system to map brain responses to how a patient processes everyday sound, speech and language. This enables audiologists and ENT specialists to assess hearing and hearing aid benefit without requiring active patient participation, offering an effective alternative for individuals with communication challenges.
Since February 2024, CORGEE is being validated in a clinical trial, in partnership with the University Hospital of Leuven and three regional children’s hearing rehabilitation centers, as part of our roadmap toward regulatory approval.
Our methodology is supported by years of scientific research. Some of our recent articles that were published in peer-reviewed academic journals: